There were 733 press releases posted in the last 24 hours and 163,681 in the last 365 days.

Stem Cell Therapy 2017 Global Market Expected to Grow at CAGR 36.52% And Forecast To 2021

The analysts forecast the global stem cell therapy market to grow at a CAGR of 36.52% during the period 2017-2021.

PUNE, INDIA, February 16, 2017 / -- Global Stem Cell Therapy Market

Stem cell therapy is the use of stem cells for the treatment or prevention of a disease or condition. Bone marrow transplant is the widely-used stem cell therapy, followed by therapies derived from umbilical cord blood. Research is being undertaken to develop various sources (such as cord blood cells, bone marrow, and skin) for stem cells, and to apply them to various disorders like neurodegenerative diseases and conditions such as heart disease, diabetes, and other conditions.

Covered in this report
The report covers the present scenario and the growth prospects of the global stem cell therapy market for 2017-2021. To calculate the market size, the report considers the sales of stem cell therapy products/segments in the market.

Get Sample Report @

The market is divided into the following segments based on geography:
• Americas

The Global Stem Cell Therapy Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
• Holostem Advanced Therapies
• JCR Pharmaceuticals
• Organogenesis
• Osiris Therapeutics
• Vericel

Other prominent vendors
• AbbVie
• American CryoStem
• AM-Pharma
• Anterogen
• apceth Biopharma
• Astellas Pharma
• Athersys
• Baxter International
• Beike Biotechnology
• bluebird bio
• Bristol-Myers Squibb
• BrainStorm Cell Therapeutics
• Brainxell
• Caladrius Biosciences
• Cellular Biomedicine Group
• Cellular Dynamics International (a subsidiary of Fujifilm)
• Cesca Therapeutics
• CHA Biotech
• Chugai Pharmaceutical
• Citospin
• Corestem
• Cytori Therapeutics
• Daiichi Sankyo
• Fujifilm
• Gamida Cell
• Global Stem Cells Group
• Grupo Ferrer Internacional
• GlaxoSmithKline
• Hemostemix
• Histocell
• International Stem Cell
• Ivy Institute of Stem Cells
• Japan Regenerative Medicine
• Kangstem Biotech
• Kiadis Pharma
• Laboratorios Salvat
• Mesoblast
• Nuo Therapeutics
• Opsis Therapeutics
• Osiris Therapeutics
• Pharmicell
• Pluristem Therapeutics
• Promethera Biosciences
• Q Therapeutics
• ReNeuron
• Salus Medical Solutions
• Sangamo Therapeutics
• Shire
• Steminent Biotherapeutics
• Sumitomo Dainippon Pharma
• Taiwan Bio Therapeutics
• Takeda Pharmaceutical
• Teva Pharmaceutical Industries
• Thoratec Corporation
• TiGenix
• Translational Biosciences
• U.S. Stem Cell
• ViaCyte
• VistaGen Therapeutics

Market driver
• Increase in federal funding in stem cell therapy
• For a full, detailed list, view our report

Market challenge
• Stringent regulatory environment affecting the product approvals
• For a full, detailed list, view our report

Market trend
• Evolution of new destinations in the development of stem cell therapies
• For a full, detailed list, view our report

Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

Complete Report Details @

Table of Contents -Major Key Points

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
• Key market highlights

PART 05: Understanding of stem cell therapy
• History of stem cell research

PART 06: Ethical issues and regulatory landscape
• Ethical issues of stem cell research at different phases of research

PART 07: Key clinical trials
• Attractive clinical trial locations to invest
• Commercially attractive therapy areas to invest

PART 08: Market landscape
• Market overview
• Five forces analysis

PART 09: Market segmentation by therapy
• Allogeneic stem cell therapy
• Autologous stem cell therapy

PART 10: Market segmentation by applications
• Dermatology
• Musculoskeletal
• Cardiovascular

PART 11: Geographical segmentation
• Stem cell therapy market in Americas
• Stem cell therapy market in EMEA
• Stem cell therapy market in APAC

PART 12: Market drivers
• Limitations in traditional organ transplantations fueling the demand for stem cell therapies
• Increase in federal funding in stem cell therapy
• Growing demand for personalized medicine
• Increasing demand to develop effective drugs for cardiology and degenerative disorders

PART 13: Impact of drivers

PART 14: Market challenges
• Stringent regulatory environment affecting the product approvals
• Critical ethical challenges with respect to stem cell research
• High cost of clinical trials and failure rate in clinical trials

PART 15: Impact of drivers and challenges

PART 16: Market trends
• Evolution of new destinations in the development of stem cell therapies
• Increasing inorganic growth strategies such as acquisitions and licensing agreements
• Growing focus on the development of drugs for emerging applications
• Increasing investments from private enterprises likely to fuel market growth


Buy Now@



Partner Relations & Marketing Manager

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

About Us

Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.

Norah Trent
+1 646 845 9349 / +44 208 133 9349
email us here